Moreover, the positivity of TP53 R249S mutation in cfDNA proved to be useful also as prognostic biomarker in a large study involving 895 HCC patients, being a predictor of poorer OS and shorter progression-free survival (PFS) in patients with or without liver resection [61]. The gene discussed is TP53; the disease is hepatocellular carcinoma.